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CHAPTER 1
Introduction
1.1 RNA
For many years, ribosomal RNA (rRNA) was only considered a scaffold molecule that
bound and organized the ribosomal proteins, which were assumed to be the catalytic components
of ribosomes. It wasn’t until 1967 that Carl Woese suggested that RNA itself could be catalytic,
leading to the RNA world hypothesis.

1

In 1982, Thomas Cech was the first to show that RNA

was catalytic and could participate in cellular functions. 2 Sidney Altman also showed how RNA
was essential for enzymatic activity.137 Together, Cech and Altman were awarded the Nobel
prize in chemistry in 1989 for their discoveries of catalytic properties of RNA. 74; 75 Since then,
many catalytic RNAs or ribozymes and a large array of functionally important non-coding
RNA’s have been identified,

3; 4; 5; 6; 7; 8

demonstrating the importance and complexity of RNA in

cellular functions. Fittingly, even simple linear RNA strings of adenine, cytosine, guanine and
uracil are known to form a myriad of elaborate secondary and tertiary structures that rival the
complexity of proteins.9;

10

The ability to form complex three-dimensional structures is one

characteristic that allows RNA to play multiple roles in biological systems. As our ideas of the
limitations of RNA dissolve, we watch the growing clout of this structurally and functionally
dynamic molecule stretch from interfering RNAs to riboswitches and various essential
ribozymes.76; 77; 78; 79

1.2 RIBOSOME
Many genes are required to build and maintain replicating cells. In all cells, genetic
information is stored as DNA and transcribed to RNA, and in many cases, translated into

2
proteins. Three types of RNA are directly involved in protein synthesis (translation); messenger
RNA (mRNA) contains the genetic information, transfer RNA (tRNA) is an adaptor molecule
that carries the amino acids that will be assembled into proteins, and ribosomal RNA (rRNA) is
the functional core of ribosomes, which are the ribozymes responsible for assembling amino
acids into proteins by reading the genetic message in mRNA.
Ribosomes are composed of ribosomal RNA (rRNA), the catalytically active component,
and ribosomal proteins (rproteins), which serve primarily to optimize the tertiary structure by
folding the rRNA into its active three-dimensional conformation. Though there are differences
in the size and complexity of prokaryotic and eukaryotic ribosomes, they all follow the same
general composition and structure, and contain the same phylogenetically conserved regions. In
fact, portions of ribosomal RNAs are among the most highly evolutionarily conserved sequences
known, which is why rRNA is often used in molecular phylogeny studies. Escherichia coli (E.
coli) is a commonly used model organism for ribosome research, because the mechanism of
protein synthesis is similar in all organisms.

1.3 SUBUNITS
The ribosome is one of the largest and most complex structures in the cell, composed of
three different RNA’s and 55 different proteins in bacteria (figure 1.1). Ribosomes are abundant
in the cell, about 70,000 per actively growing E. coli cell, and use 85%-95% of the cells
available energy.17;

29; 80

E. coli’s 70S ribosome is 20 nm in diameter, 2.6-2.8 mDa, and

approximately 65% rRNA and 35% rproteins. 12;

13

The 70S ribosome is composed of a 30S

subunit and a 50S subunit.14 Formation of mature 70S ribosomes depends on correct subunit

3

Figure 1.1: Composition of the Prokaryotic 70S Ribosome
The prokaryotic ribosome is composed of 30S and 50S subunits. The 30S is composed of 16S
rRNA and 21 ribosomal proteins. The 50S is composed of 23S rRNA, 5S rRNA and 34
ribosomal proteins.
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assembly and association. The 30S subunit is composed of the 16S rRNA (1542 nucleotides
long) and 21 rproteins (figure 1.1). 16 These proteins may be classified by the order in which they
bind during the assembly process as primary, secondary, tertiary, and quaternary proteins (figure
1.2). Primary rproteins (S4, S7, S8, S15, S17, and S20) bind to naked 16S rRNA to form a preRNP complex. Only after the pre-RNP complex is formed and conformational changes have
taken place can the secondary rproteins (S6, S9, S12, S13, S16, S18, and S19) bind. Next, the
tertiary rproteins (S5, S6, S10, S11 and S14) bind, and finally the quaternary rproteins (S2, S3
and S21) bind to form the fully assembled 30S subunit. 11
The 50S subunit is composed of RNA and proteins as well, though the assembly process
is more complex because of its size. It begins as naked 23S and 5S rRNA and combines with 34
rproteins. The 23S rRNA is 2923 nucleotides and the S5 rRNA is just 122 nucleotides. Just as
the 30S goes though a highly ordered pathway to maturation, the 50S rproteins are highly
dependent on each other for binding.32 It has been difficult to study the rRNA intermediates
during 50S assembly, mostly due to the lack of an appropriate experimental strategy. Crystal
structures of the 50S show placement of the rproteins, and some studies have solved a few
intermediate steps.18; 19
1.4 ASSEMBLY
There are seven ribosomal RNA operons in the genome of E. coli and each one contains
all three of the rRNAs (23S, 16S and 5S). 123 As the RNA polymerase transcribes the operon, one
long strand of RNA is made. As it is being transcribed, the rRNA transcript folds into a series of
secondary structures that form site specific cut sites for RNases that process the RNA into the
16S, 23S and 5S, as seen in figure 1.3.43 Following formation of the individual rRNA molecules,
little processing occurs. As the rRNAs for each subunit are being transcribed, rproteins also bind

5

Figure 1.2: The Assembly Diagram for the 30 S Subunit.
Primary binding proteins are in blue, secondary binding proteins are in red, and tertiary binding
proteins are in green. Primary binding proteins bind directly to the 16S ribosomal RNA.
Secondary binding proteins bind to structures formed by binding of primary proteins while
tertiary proteins bind to structures formed by the binding of both primary and secondary proteins.
Adapted from Talkington, Megan W. et al, 2005. 38

6
into individual components, which may be reconstituted into active subunits and fold them
sequentially, into mature subunits.23 Both ribosomal subunits can be broken down in vitro.24
Reconstitution experiments have been used to explain the hierarchy of protein binding leading to
cooperative assembly of the subunits. 26;27;28 Assembly of the 30S occurs in steps with the
sequential association of specific rproteins that induce conformational changes in the rRNA,
allowing for the next set of rproteins to bind (see figures 1.2 and 1.4). Binding of one of these
proteins, S16, causes a conformational switch that stabilizes pseudoknots in the 30S and helps to
prevent formation of incorrect conformations. 35
Ribosomal proteins generally do not make base-specific contacts with rRNA, but instead
bind to specific structures in the rRNA or make specific charge interactions.34

rProteins

generally have two domains; a globular domain that is found on the surface of the ribosome, and
an extended domain that penetrates into the rRNA core of the subunits. 31 The majority of the
rprotein extended regions stabilize the interaction between the protein and the rRNA as well as
reducing the electrostatic clash between the phosphate backbones. Fine morphological features
are resolved with late protein-protein interactions.25 As many rproteins can be deleted without
affecting translation, it has been concluded that the role of rproteins is to stabilize and assist
ribosomal RNA folding.

No rproteins are found in the peptidyl transferase center or the

decoding region of the ribosome and this has been cited as further evidence that rproteins play
mostly a structural role. 85
1.5 PROTEIN SYNTHESIS
Protein synthesis is a process where mRNA is recognized and moved through the
decoding region of the ribosome along with tRNA, catalyzing the formation of a peptide.
rRNA’s form the structural core of the ribosome, with the proteins as secondary elements. There

Figure 1.3: Processing of Ribosomal RNA Operon
Colored lines indicate mature rRNA. RNases shown; 1.RNase III, 2. RNaseP, 3. RNaseF, 4.RNase E, 5. RNase M16, 6. RNase
“M23”, 7. RNase “M5”. Adapted from Gegenheimer and Apirion, 1981.

7

8

Figure 1.4: An Assembly Landscape for the 30S Ribosomal Subunit
This diagram illustrates the relationship between folding pathways, ribosomal proteins and free
energy. The horizontal axes of the surface correspond to 16S rRNA conformational space, and
the vertical axis is free energy. In the absence of proteins, the RNA cannot reach its lowestenergy conformation. Local folding creates binding sites for proteins (colored spheres), which,
upon binding, create large changes in the assembly landscape. Though various folding pathways
exist, sequential protein binding eventually stabilizes the native 30S conformation in the most
energetically favorable conformation. Image taken from Talkington et al, Nature 2005. 38
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are no proteins within 18Å of the peptidyl transferase region, and it has been shown that upon
deletion of most rproteins, the depleted rRNA can still catalyze peptide bond formation.

84; 85

These findings clearly show that the ribosome is a ribozyme.
Each subunit is responsible for specific functions, such as decoding by the 30S and
peptidyl transferase activity within the 50S.33 Though the individual subunits are capable of
performing parts of protein synthesis alone (in vitro)141; 142, a mature 70S is required to transcribe
an entire protein. Usually, the 30S and the 50S subunits exist separately in the cell unless they
are actively translating mRNA. There are three recognized stages of protein synthesis; initiation,
elongation, and termination.
1.6 INITIATION
In bacteria, the initiation complex forms in three steps with the help of three initiation
factors and a single GTP (figure 1.5). Initiation factor 1(IF1) binds the free 30S subunit at the Asite to block incoming aminoacyl-tRNA’s while IF3 binds the 30S to prevent the 50S from
binding.81; 82 At the 3' end of the 16S RNA is a feature of the primary structure called the antiShine-Dalgarno (ASD) sequence. During initiation, the ASD forms Watson-Crick (WC) base
pairs with a complementary sequence called the Shine-Dalgarno (SD) sequence which is located
upstream of the start codon in most bacterial mRNAs.15 The SD-ASD interaction places the
mRNA AUG start codon in the ribosomal P-site. The SD sequence in E. coli is characterized by
a pyrimidine rich sequence, though some SD regions are difficult to recognize because there is
no distinct sequence. Some mRNAs have been shown to lack a SD sequence all together and can
still be translated in vivo, albeit with an affinity for the 30S at an order of magnitude lower than
mRNAs with the SD sequence.22 The degree of complementarity between the SD and the ASD

10

Figure 1.5: Translation Initiation
See text for details. Image copyright of Pearson Education, Inc. 2009.

11
influences the efficiency of translation of mRNAs and mutations in the SD sequence have been
shown to reduce translation due to weakened mRNA-ribosome complementarity.21
In bacteria, the start codon of most mRNAs is AUG, which encodes formyl methionine
bound to the initiator tRNA that binds specifically to the ribosomal P-site. Step two of initiation
occurs once the start codon is positioned properly at the P-site. IF2, a GTPase

83

, is bound to

GTP and fmet-tRNAfmet, and joins the complex in such a way that the tRNA anticodon is
correctly paired with the initiation codon in the mRNA. In the final step of initiation, the 50S
joins this complex. As simple and straight forward as this sounds, the interaction between the
two subunits is actually mediated through a series of at least 12 RNA-RNA, RNA-protein, or
protein-protein intersubunit bridges.30
Most of the RNA-RNA bridges are found close to the functional sites of the ribosome,
while the others are found mainly towards the margins.87 Some intersubunit bridges are dynamic
and must be disrupted during each translocation event during elongation and may interact with
associated tRNA’s.40; 86 When the 30S and 50S are properly positioned, the GTP bound to IF2 is
hydrolyzed and all three initiation factors are released. When the two subunits assemble, a cleft
or channel forms that allows the mRNA and tRNA’s to pass through during elongation. 138; 139
1.7 ELONGATION
In the elongation stage seen in figure 1.6, three principle steps occur during each cycle:
the mRNA codon is recognized by the correct tRNA, a peptide bond is formed between the
incoming amino acid (bound to tRNA) and the nascent peptide, and finally the tRNAs bound to
the ribosome are translocated to the next position to create an available tRNA binding site for the
next cycle.

12

Figure 1.6: Translation Elongation
See text for detailed description.
Image taken from <http://kvhs.nbed.nb.ca/gallant/biology/translation_elongation.html>

13
The process of elongation begins with the formation of a ternary complex between
elongation factor-Tu (Ef-Tu), GTP, aminoacylated tRNA (aatRNA) and the ribosome. Once the
complex of EF-Tu, GTP and aatRNA binds, the anticodon-stem loop (ASL) of the tRNA moves
into the A-site of the 30S subunit, base pairing with the mRNA codon. 89

If the tRNA in

position is the cognate tRNA, the 30S subunit undergoes a conformational change. 90; 91 This
conformational change leads to the hydrolysis of GTP by EF-Tu and the release of EF-Tu from
the complex.91; 92
With the correctly coded charged tRNA in place, a peptide bond can be formed. The
actual formation of the peptide bond is catalyzed by the peptidyl transferase center, which is
formed by folded portions of the 23S rRNA within the 50S subunit. The initiating formyl
methionine is transferred from its tRNA to the amino acid group on the tRNA in the A-site, a
process called transpeptidation. The amine from the new amino acid on the tRNA bound at the
A site attacks a carbonyl at the end of the growing peptide chain in the P site. Formation of this
peptide bond creates a dipeptidyl-tRNA in the A-site, which shifts position in the 50S to form a
hybrid binding state between the A-site and P-site of the ribosome (figure 1.7). 94 The uncharged
tRNA in the P-site tilts to one side so that its 5' and 3' ends are in the E-site.96 Similarly, the
charged tRNA in the A-site tilts so that its 5' and 3' ends (and the growing peptide chain) are in
the P-site. The anticodons, however, of the uncharged and charged tRNA’s still remain in P-site
and A-site, respectively. Ribosomal translocation is catalyzed by elongation factor G (EF-G),
which is released from the ribosome after hydrolysis of GTP. 93 These tRNA’s need to be moved
in order to allow new aminoacylated tRNA’s to enter. This process, called translocation, results
in the movement of tRNA’s from the A-site to the P-site, or from the P-site to the E-site via P/E
and A/P hybrid states.94

Figure 1.7: Hybrid-State Model
Schematic of tRNA-binding states on the ribosome. In the transition of tRNA binding in the A/A and P/P sites (30S subunit and
50S subunit, respectively) to occupy hybrid binding sites (A/P and P/E for 30S/50S sites). Letters indicate the locations of the
aminoacyl (A), peptidyl (P) and exit (E) tRNA binding sites. Image modified from Zhang et al., 2009 Science. 96
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15
In the process of translocation, tRNAs cycle through three sites of the ribosome, A
(aminoacyl)-site, P (peptidyl)-site and the E (exit)-site.88 GTP dependant EF-G, also known as
translocase, enhances this movement by stabilizing the hybrid-state conformation of the 70S
ribosome, causing framshifting.95 Because the structure of EF-G mimics the structure of EF-TutRNA, it presumably binds the A-site and displaces the peptidyl-tRNA in a ratchet-like
movement. Translocation and transpeptidation continue as the peptide chain grows. The newly
uncharged tRNA is displaced from the P-site to the E-site, and is then released into the cytosol.
1.8 TERMINATION
The translation of a polypeptide chain terminates when one of three stop codons (UAA,
UAG, UGA) enters the A-site (figure 1.8). Stop codons have no cognate tRNA’s. When a
termination codon occupies the A-site of the ribosome, one of two release factors (RF) will
recognize it and bind to the A site, signaling the termination of peptide elongation.

RF1

recognizes UAG and UAA stop codons, and RF2 recognizes UGA and UAA stop codons. 124; 125
Binding of a RF results in the peptidyl transferase center hydrolyzing the ester bond between the
tRNA and polypeptide from the P-site tRNA, releasing the nacent protein. 127;

140

. Another

release factor, RF 3, is thought to release the ribosomal subunits, but is not essential for cell
survival.126
1.9 16S RIBOSOMAL RNA STRUCTURES AND REGIONS
All ribosomal RNAs form similar secondary structures. To analyze these structures,
ribosomes are separated into domains and secondary structures or regions.

The secondary

structure of 16S RNA is divided into four domains; the 5' domain, the central domain, the 3'
major domain and the 3' minor domain (figure 1.9 and 1.10). These domains form the

16

Figure 1.8: Translation Termination
See text for detailed information. Image taken from Garland Science, Copyright © 2002
http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=genomes&part=A7712
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Figure 1.9: E.coli 16S Ribosomal RNA Secondary Structure
Image taken from Noller, H.F. <rna.ucsc.edu/rnacenter/ribosome_images.html>

18

Figure 1.10: E. coli 16S Ribosomal RNA
Image modified from PDB 2I2P

19

Figure 1.11: Morphological Features of the 30S rRNA
16S rRNA is in blue; 30S rproteins are in cyan; Red (RNA-RNA) and orange (RNA-protein and
protein-protein) regions are involved in subunit association contacts.14

20
body, platform and head of the 30S subunit (figure 1.11). The 5' domain (nucleotides 1-559)
makes up the bulk of the 30S body and consists of 19 helices. The central domain (nucleotides
560-918) is composed of nine helices that forms the 30S platform.

The 3' major domain

(nucleotides 919-1396) contains 15 helices that form the head, and the 3' minor domain
(nucleotides 1397-1542) is just two helices that extend from the subunit to interact with the 50S
subunit.
Within each of these domains are several secondary structure motifs that include singlestranded regions, double-stranded regions (helices), internal loops, internal budges, and stem
loops. Single-stranded regions are unpaired nucleotides that often interact with other structural
elements. Double-stranded regions, or helices, take on the basic A-form helix structure from
anti-parallel single stranded regions of rRNA. The A-form helix generates a deep but narrow
major groove (4-5Å width and 13.5Å depth) which makes protein interactions difficult (see
figure 1.12). The minor groove, is broader and shallower than the major groove (10-11Å width
and 2.8Å depth) it is for this reason that, unlike DNA, many RNA interactions occur in the minor
groove.12; 45 Unpaired bases within these helices may form internal loops or bulges. In bulges,
one strand has uninterrupted base pairing, but the other strand has unpaired bases that bulge out.
Internal loops are similar, but both strands have unpaired bases. These unpaired bases have the
ability to interact with other ribosomal elements.

Finally, stem-loops or hairpin-loops are

composed of a single continuous strand of RNA that folds over on itself with an inverted
complementary sequence, leaving only a small region of unpaired nucleotides (usually four or
more) at the end of the helix. The most common type of loop is the tetraloop, making up nearly
55% of all stem loops in the 16S rRNA . 36

21

Figure 1.12: RNA A-form Helix
A-form RNA helix, showing major and minor grooves. Refer to text for detailed description.
Adapted from White, et al (2002)45

22

Figure 1.13: Common Secondary Structural Motifs
A) stem/hairpin loop ; B) internal bulge; C) internal loop; D) junction loop. (Schuwirth et al.,
2005) 44

23
Tertiary structural motifs are formed by interactions between secondary structures
(Figure 1.13). RNA tertiary structures may involve (a) two helices, (b) two unpaired regions, or
(c) one unpaired region and a double-stranded helix.37 Under appropriate conditions, structured
RNA molecules undergo further modeling to occupy specific 3-D structures. It is this level of
organization that provides the complexity in RNA that is indispensable for its catalytic activity.
These precise three dimensional structures allow the refined function of the finely tuned
ribosome. There are several common tertiary structures; co-axial stacking, adenosine platforms
(A-platforms), base triples, loop-loop interactions, tetraloop-tetraloop receptors, ribose zippers,
and pseudoknots (figure 1.14). Co-axial stacking is an energetically favorable motif in which
helices are stacked to form a semi-continuous helix.144 The A-platform is an interaction between
two adjacent adenosines stacking onto a non-canonical base pair.143;
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A base triple is the

interaction of an unpaired nucleotide with a Watson -Crick base pair in either the major or minor
groove.145 Loop – loop interactions involve the formation of Watson-Crick base pairs between
existing complementary hairpin loops. 143 Tetraloop receptors are among the most prevalent
motifs observed in natural RNAs, which is the interaction of nucleotides between four nucleotide
loop sequences.

143; 145; 146

The ribose zipper is distinguished by consecutive hydrogen-bonding

between the ribose 2'-hydroxyls from different regions of an RNA chain or between different
RNA chains.147 Pseudoknots, though more of a folding topology than a specific structure, are
characterized by two stem-loops, of which the loop regions form short double helices by
interacting with upstream or downstream sequences. 148
1.10 PSEUDOKNOTS
Pseudoknots are among the most prevalent motifs in RNA structures.

Originally

recognized in the yellow turnip virus42, their complex tertiary interactions made them difficult to

Figure 1.14: Common Tertiary Structural Motifs
(a) Coaxial stacking: Two coaxially stacked helices (blue and violet) along with the single-stranded region (orange). PDB 1DRZ.
(b)Base triplets: from 30S crystal structure. PDB 1IBM. (c) Adenosine platform: Adenosine shown in yellow.166 (d)Loop loop
interaction: Red and yellow correspond to different external (hairpin) loops. (e)Ribose zipper: Hydrogen-bonding in the A-minor
motif and ribose zipper tertiary interactions are illustrated with dotted lines. PDB1CXO. (f)Tetraloop-tetraloop receptor.
Tetraloop shown in red and the receptor is shown in green. PDB1HR2. (g)Pseudoknot: See text for details167
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recognize and predict. Though several pseudoknot topologies exist, they are generally
recognized as two helical segments connected by single-stranded regions or loops (figure 1.15). 41
Based on the length of the helix or loop, or surrounding interactions, the pseudoknot can take on
various structural conformations. Accordingly, this structure has been at the core of diverse
functional hotspots. 50-57; 70-71
The best characterized and most commonly occurring pseudoknot topology is the H-type,
where H stands for hairpin loop.46 In this type of fold, the unpaired bases of the loop in a stem
loop form pairs with bases outside of the stem. These new base interactions cause the formation
of a second stem and loop, which can stack on top of each other due to hydrogen bonds
stabilizing the structure. This coaxal stacking of the stems means the pseudoknot mimics a
single stem, making the pseudoknot a difficult structure to identify. In most cases, the second
loop is very short, or completely absent. 49 Figure 1.16 shows other types of pseudoknots that
have longer loops than the traditional H type and can take on secondary structures of their own;
LL type, HLOUT type, HLIN type, HH type, and the HHH type (H: hairpin loop, L:bulge loop,
internal loop or multiple loop).47 Although various conformations have been identified, for
many of these pseudoknots, much of their primary sequence is unimportant to the function of the
structure as long as the conformation and overall stability is maintained. 48
RNA pseudoknots are seemingly “everywhere” and are essential for many important
biological processes. They have been found in various ribozymes51; 52, self splicing introns53,
telomerase50, riboswitches70; 71, frame shifting viral RNAs54; 55; 56; 57, and other active sites. These
pseudoknots are not simply RNA architecture, they are often catalytically active in biological
systems. Two of the fastest-known ribozymes, the hepatitis delta virus67 and one capable of
forming Diels-Alder reactions66, both harbor nested pseudoknot structures128; 129 which is when
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Figure 1.15: Folding of an RNA Pseudoknot
(A) Linear arrangement of base-pairing elements within an H-type RNA pseudoknot. Base
pairing is indicated with dashed lines. (B) Formation of initial hairpin within pseudoknot
sequence. Base pairings from loop to bases outside the hairpin are indicated with dashed lines.
41
(C) Classic H-type pseudoknot fold. (Staple and Butcher 2005)

Figure 1.16: Pseudoknots of Other Types
First image: H type (A) LL type; (B) HLOUT type; (C) HLIN type; (D) HH type; (E) HHH type.
H: hairpin loop, L: bulge loop, internal loop, or multiple loop.
47
Taken from Kyungsook Han and Yanga Byun (2003)
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two pseudoknots stack on top of each other. Some well studied (group I) spliceosomes include
pseudoknot structures, in Tetrahymena, for example, that hold the molecule together and
establish the catalytic core.58

Human telomerase has a highly conserved classic H type

pseudoknot at its 5' end that is essential for function. 59;
directly linked to the diseases aplastic anaemia61;

63

60

Loss of this pseudoknot has been

, bone marrow failure62;

Syndrome130, and autosomal dyskeratosis congenita131;

63

64,

Cri du chat

Pseudoknots are also commonly

responsible for the induction of ribosomal frameshifting, and are therefore a critical component
of this type of regulation of gene expression.

At a slippery sequence in the mRNA, the

pseudoknot causes the ribosome to stall and the codon frame is disrupted and realigned at a -1
position for a new reading frame. 65 A number of viruses use this mechanism for proliferation of
retroviruses and it is therefore an attractive target for antiviral drugs.
In E.coli, four pseudoknots have been identified in the 16S subunit, and another 15 are
predicted to be in the 50S subunit. In the 16S, the central pseudoknot exists between nucleotides
9-13/21-25, and between 17-19/ 916-918. Powers and Noller showed another pseudoknot in the
530 hairpin region exists between 505-507/524-526, and that this pseudoknot is essential for
ribosome function.72 A third pseudoknot, also found in the central domain is between 570571/865-866, is also essential for ribosome function. 73 Pseudoknots can play many different
roles; stable pseudoknots can offer binding sites for proteins or other RNA’s, assist in overall
folding and/or fitness of a molecule (as unfolding a pseudoknot can be difficult) 69, or take on
different conformations in response to environmental changes, 68 can be a dynamic structure
needing to break and re-form.
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1.11 GENETIC SYSTEM
Early biochemical studies have contributed to our basic general knowledge about
ribosomal assembly and translation. However, more detailed information was concealed because
of three problematic features of using E. coli as the model system; the presence of multiple
ribosomal operons, not being able to study dominant lethal rRNA mutations, and the difficulty of
separating plasmid derived and chromosomally derived ribosomes. Prokaryotic ribosomes use
the SD-ASD interaction to bind mRNAs and initiate translation.
Lee et al.98 took advantage of this critical interaction to develop an in vivo genetic system
for the analysis of the role of ribosomal RNA in protein synthesis. (Figure 1.17). In this system,
the complete rrnB operon (including the 16S, 23S and 5S), is under control of a lacUV5
promoter which can be induced by IPTG (Isopropyl β-D-1- thiogalactopyranoside).97; 98; 99 This
plasmid also contains a lacIq geneencoding the lac repressor132 to facilitate regulation of rrnB
transcription.

An ampicilin resistance marker is included under a constitutive promoter to

maintain the plasmid in the cell. Two reporter genes, green fluorescent protein (GFP) 133; 134 and
chloramphenicol acetyltransferase (CAT) 136, are under a constitutive trp promoter135. The SD
sequences of the reporter genes as well as the ASD sequence of the 16 S rRNA were mutated
from 5’-CCUCC to 5’-GGGAU.97; 100
This modified sequence allows only ribosomes with the specialized ASD sequence can
translate the reporter genes and nothing else. Consequently, cells expressing this system are
chloramphenicol-resistant and the level of this resistance and the amount of GFP fluorescence
produced is directly dependent upon the amount of functional CAT protein and GFP produced by
the plasmid-derived ribosomes. Thus, deleterious rRNA mutations in plasmid-encoded
ribosomes inhibit translation of only the CAT and GFP messages, resulting in lower
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chloramphenicol resistance and fluoresence without affecting translation of other cellular
messages. Minimum inhibitory concentration (MIC) of chloramphenicol and/or GFP
fluorescence can be assayed directly from an induced culture, allowing the coveted feature of in
vivo analysis with minimal preparation.

Figure 1.17: Genetic System for Analysis of Ribosome Function
Plasmid pRNA228 contains the rrnB operon under transcriptional regulation by the lacUV5
promoter. The anti-Shine Dalgarno sequence in the 16S rRNA has been altered, as well as the
Shine Dalgarno sequence in both reporter genes CAT and GFP. Red and blue oval represent
plasmid derived 30S and 50S subunits, respectively. Gray ovals represent host chromosomally
derived 30S and 50S subunits. As the reporter genes cannot be translated by host ribosomes, this
system allows for the analysis of plasmid derived ribosomes exclusively without affecting the
viability of the cell. 39
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Chapter 2
Materials and Methods
2.1 REAGENTS
Restriction enzymes and buffers were purchased from New England Biolabs. Sequencing
DNA polymerase, nucleotides, and buffer were purchased from Epicentre Biotechnologies. PCR
primers and IRD labeled sequencing primers were ordered from IDT DNA. Silica for DNA
purification was purchased from Sigma-Aldrich. DNase I was purchased from Worthington
Biochemical Corporation.

Other chemicals were purchased from either Sigma-Aldrich or

Thermo-Fisher Scientific.
2.2 BACTERIAL STRAINS
All plasmids for rRNA mutagenesis and analysis were maintained and expressed in E.
coli DH5 (supE44, hsdR17, recA1, endA1, gyrA96, thi-1, relA1).109 If methylation sensitive
enzymes such as BclI restriction endonuclease were employed, the plasmid was cultured from
either E. coli GM2929102 (dam-13::Tn 9, dcm-6, hsdR2, recF143, mcrA0, mcrB9999, galK2,
galT22, ara-14, lacY1, xyl-5 thi-1, tonA31, rpsL136, hisG4, tsx-78, mtl-1, supE44, leuB6, rfbD,
fhuA13) or E. coli ER2925103 (ara-14, leuB6, fhuA31, lacy1, tsx78, glnV44, galK2, galT22,
mcrA, dcm-6, hisG4, rfbD1, R(zgb210::Tn10),TetS, endA1, rpsL136, dam13::Tn9, xylA-5, mtl-1,
thi-1, mcrB1, hsdR2). Strains were transformed by electroporation106 using a Gibco-BRL Cell
Electroporator or chemically transformed using TSB competent cells.109
2.3 MEDIA
All cultures were grown in Luria-Bertani (LB)104; 105 medium or LB medium containing
100µg/mL ampicillin (LB-Amp 100), and/or 35µg/mL kanamycin (LB-Km 35). Solid media
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were made by adding Bacto Agar (1.8% W/V). To induce synthesis of plasmid-derived rRNA
from the lacUV5 promoter in pRNA plasmids, IPTG (isopropyl-beta-D-thiogalactopyranoside)
was added to a final concentration of 1 mM. To induce synthesis of cloned ribosomal proteins
under the PBAD promoter in pKan5 plasmids, L-Arabinose was added to a final concentration of
0.2%. A solution of Medium E + 21% DMSO was used for freezer storage of bacterial strains.
Medium E is composed of K2HPO4 (2% W/V), NaNH4HPO4•4H2O (0.7% W/V), citric acid
(0.4% W/V), MgSO4•7H2O (0.04% W/V), and DMSO (21% V/V). SOB medium106 used for
preparation of DH5 electrocompetent cells was made by addition of bacto-tryptone (2% W/V),
bacto-yeast (0.5% W/V), NaCl (0.05% W/V), and KCl (2.5mM final concentration). SOC
medium109 was prepared as directed for Difco™ SOB Medium and used for the recovery of
transformed cells; Per liter; 20g tryptone, 5g yeast extract, .5g NaCl, 2.4g anhydrous magnesium
sulfate, 186mg KCl. No glucose was added.
2.4 PLASMIDS
The pWK122 plasmid is a derivative of pWK1.110 In pWK122, however, the 3' terminus
of the rrsB gene has been modified such that the Shine-Dalgarno sequence and the sequence
downstream from the rrsB gene are identical to the corresponding sequence in pRNA
plasmids.39; 110 The rrsB genes in the pWK plasmids are under the transcriptional regulation of a
Class III T7 promoter116 and were used only as a cloning intermediate for site directed
mutagenesis because they have more unique restriction sites than the larger pRNA vectors
(figure 2.1). The pRNA228 and pRNA272 plasmids are derivatives of the original pRNA123
vector63 and contain the same rrnB operon with an altered Shine Dalgarno sequence under a
transcriptional lacUV5 promotor, a lacIq repressor, GFP and CAT reporter genes, a copy of the
23S and 5S. These plasmids are all dervitives of pRNA123 39 which was constructed from
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pBR322150. GFP assays were performed using the pRNA228 plasmid with mutations in the 16S
gene at sites corresponding to positions 570, 571, 865, 866 of E. coli 16S rRNA.
The pKan5 plasmids are derivatives of pACYC177151 and therefore have a low-copy
number (10-12 copies per cell) and are compatible with ColE1-derived plasmids such as the
pRNA series plasmids.107 The pKan5 T1T2 expression vector (figure 2.2) was used to overexpress certain ribosomal proteins in the presence of the plasmid-encoded ribosomes. pKan5
confers kanamycin resistance.

Ribosomal protein genes cloned into the HindIII and NotI

restriction sites are placed under the transcriptional regulation of the PBAD promoter.153
2.5 CONSTRUCTION OF SITE-DIRECTED MUTATIONS
Mutations were introduced into the 16S rRNA gene using recombinant PCR.

153

pWK122

was used as a template during PCR with primers 570N571N and 16S-H796 for mutations at
positions 570 and 571 and primers 865N866N and AVRII for mutations at positions 865 and 866
(table 2.1). PCR reactions contained 1µM of each primer, 50 ng template, 200 µM dNTPs, 4
units Pfu polymerase and 1X Pfu Buffer (200mM Tris-HCl pH 8.8, 20mMMgSO4, 100mM KCl,
100mM (NH4)2SO4, 1% Triton X-100, 1mg/mL BSA) in a 50uL reaction. The PCR products
were gel purified and recovered using silica beads. The products were then digested with BglII
and SacII, and ApaI and BglII, respectively. The 570, 571 mutations were first subcloned into
pWK122 and verified by sequencing (figure 2.3). Each mutation was then transformed into
either GM2929 or ER2925, both of which are recombination and dam methylase deficient
strains. The mutations were then transferred from pWK122 to pRNA228 using the BclI and
BstEII restriction sites and confirmed by sequence analysis. The 865, 866 mutations were cloned
directly into pRNA272 and verified by sequencing (figure 2.4). Finally, 865, 866 mutations
were digested with BglII and BstEII and ligated into both wild-type pRNA228 and pRNA228
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Figure 2.1: Commonly used plasmids.
pWK122 on the left and pRNA228 on the right. See text for details.

Figure 2.2: pKan5 T1T2
This plasmid is the empty version of the vector. Ribosomal protein genes were cloned
between the NotI and HindIII restriction sites. See text for details.
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with each 570, 571 mutation sets (figure 2.4 and 2.5). Once each of the 255 combinations of
mutations were identified and confirmed by sequencing, the mutants were stored at -80 °C.
2.6 DNA PURIFICATION
PCR products and digested DNA fragments were purified by electrophoresis in 0.8-1.2%
SeaKem® GTG® agarose gels and excising the correct sized band and gene cleaning.111 The
agarose and DNA was melted in three volumes of a NaI solution (6M NaI, 1X TAE, 10mM
Na2S2O3) and incubated at 55°C. Approximately 5µl (100ng) of silica was added, and an extra
1µ of silica was added for each 0.5µg of DNA exceeding 5µg. The silica was mixed with the
sample for 15 minutes by gentle inversion and pelleted by centrifugation for 1 minute at 12,000 x
g The silica pellet bound to the DNA was washed three times with a high-salt New Wash
solution (50mM NaCl, 10mM Trish-Cl pH 7.5, 2.5mM EDTA, in 50% ethanol in autoclaved
deionized water). The pellet was dried under vacuum for 5 minutes at 55°C to remove trace
amounts of ethanol. Purified DNA was eluted from the pellet with sterile de-ionized water.
Plasmid DNA was isolated using the alkaline lysis miniprep method. 112 For overnight cultures, 3
mL of LB medium containing 100µg/mL ampicillin were inoculated with a single colony and
incubated at 37°C with shaking overnight (16 hrs). The cells were pelleted by centrifugation for
1min at 4,000 x g, and resuspended in 300µL of resuspension solution (50mM Tris-HCl pH 7.5,
10mM EDTA, 100µg/mL RNase A) vortexing. The cells were lysed by the addition of 300µL
fresh lysis solution (200mM NaOH, 1% SDS, sterile water by gentle inversion 3-5 times, and
neutralized by adding 300µL neutralization solution (1.32M KOAc pH4.8. Bring to pH with
acetic acid) and inverting gently 3-5 times.

Cellular debris and chromosomal DNA were

removed by centrifuging for 10 minutes at 12,000 x g. Plasmid DNA was precipitated by adding
6 volumes of isopropanol and centrifugation for 15 minutes at 12,000 x g. The DNA pellet was

Ligate mutant 16S
into pRNA 228

Ligate recombinant
DNA into pWK122

Figure 2.3: Experimental approach for construction of 570N, 571N mutants.
See text for details.

Remove 16S from pRNA228

Digest mutant 16S
from pWK122

Digest with
Bgl II/ Sac II
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Figure 2.4: Experimental approach for construction of 865N, 866N mutants.
See text for details.

pRNA228

Bgl II/ BstE II

DNA into pRNA272

Bgl II/ Apa I

Ligate into

Ligate Recombinant

Digest with

Digest w/

Recombinant PCR
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Digest with Bgl II/ BstE II

Digest with Bgl II/ BstE II

Ligate

Figure 2.5: Experimental approach for saturation mutagenesis
Approach to clone 570,571,865, and 866 mutations into pRNA 228. See text for details.
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washed with 500µL of 70% ethanol and pelleted again for 5 minutes at 12,000 x g. The pellet
was dried under vacuum at 55°C for 5 minutes, and resuspended in 30µL sterile diH 2O.
2.7 LIGATION
Ligation reactions were carried out by the method of Dugaiczyk et al. 113;

114

Typical

ligation reactions contained 15ng vector, 8ng insert, 2 units of T4 DNA ligase, 1X ligase buffer
and diH2O in a final volume of 10 µL. Ligations contained either 1:3 or 1:6 molar ratios of
vector to insert and for either one hour at room temperature or overnight at 16° C.
2.8 TRANSFORMATION
Electrocompetent cells were prepared by a method modified by Dower et al. 106 A 3mL
overnight culture of E. coli DH5 cells was grown in LB medium containing 15µg/mL of
nalidixic acid (LB-Nal15), and 1 mL of the overnight was used to inoculate 500 mL of SOB
medium. The SOB culture was incubated at 37 °C with vigorous shaking until the A600 was
between 0.6-0.8. The cultures were then cooled on ice and pelleted at 4°C, 4,000 x g for 15
minutes. The cells were washed twice in 100 mL of 10% sterile glycerol, and pelleted at 4°C for
4000 x g for 20 minutes. The cells were resuspended in 700 µL of sterile 10% glycerol,
distributed in 150 µL aliquots and stored at -80°C.
For transformations, 1 µL of DNA solution was mixed with 25 µL of electrocompetent
cells and the mixture was electroporated at 2.44 kV using an E. coli cell Porator (Gibco-BRL).
The transformed cells were diluted in 1mL SOC and incubated for 30-60 minutes at 37 °C with
gentle agitation to allow expression of the antibiotic resistance markers. The transformants were
then pelleted at 4,000 x g for one minute and resuspended in 100µL of the supernatant and plated
on antibiotic selection medium and incubated at 37 °C overnight. If two plasmids were being
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transformed simultaneously (pRNA228 and pKan5) then 15 ng of each plasmid was added to the
25 µL of E. coli DH5 competent cells and recovery time was between one and 1.5 hours.
E. coli strains ER2925 and GM2929 were stored as TSB competent cells. 115 Chemically
competent cells were prepared as described by Chung et al. 155 Cultures were grown in LB broth
to 0.3-0.6 A600 and pelleted by centrifugation at 1,000 x g for 10 minutes at 4°C, resuspended in
0.1 volume of TSB buffer (10% W/V PEG, 10mM MgCl2, 10mM MgSO4, 5% DMSO) on ice,
aliquoted, and stored at -80°C. For chemical transformation into TSB competent cells, 2µL of
plasmid DNA was mixed with 50µL of competent cells and incubated on ice for 30 minutes.
After incubation, 150 µL of SOC (without glucose) was added, incubated at 37°C for one hour,
and then plated on LB agar plates with the appropriate antibiotic.
2.9 SEQUENCING
Two methods were used for sequencing plasmids; a direct method and an indirect
method. In the direct method, fluorescent primers that bind directly to the DNA template to be
sequenced were used in the sequencing reaction. 154 In the indirect method, the region of the
template DNA to be sequenced was first amplified by PCR using primers with unique 5’
extensions (table 2.2). The amplicons were then diluted and combined with fluorescently labeled
sequencing primers that anneal to the unique 5’ sequences of the PCR primers in the sequencing
reaction. Sequencing reactions utilized dideoxy chain-termination using SequiTherm EXCEL II
sequencing kits from Epicenter according to the manufacturers recommendations. 97 Sequencing
products were resolved and analyzed using the LICOR Global IR2 automated sequencer (LiCORE lnc).
Typical sequencing PCR reactions contained 150 ng template, 200 nM dNTP, 1X Pfu
Buffer, 0.5 µM of each primer, and 2 units of Pfu polymerase in a 10µL volume. The PCR
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product was then diluted with 170 µL diH2O and used as a template in the subsequent
sequencing reaction.
Sequencing reactions were assembled in 96 well thin-walled PCR plates (MJ research
Inc.). Each reaction contained a 1 µL aliquot of template and a 1.1 µL aliquot of master mix into
the appropriate well. A master mix was prepared with 1 pmol/µL primers (see Table 2.3), 3.54X
sequencing buffer (final concentration of 80 mM Tris-HCl and 2mM MgCl2), dNTP’s and
5U/µL DNA polymerase according to the manufacture protocol. 1 µL of stop solution
(Epicentre) was added to each well when the reaction was finished.

Samples were then

denatured at 94°C for 3 minutes, quenched on ice for 5-10 minutes, and loaded on a 6%
denaturing polyacrylamide gel. The sequences were aligned using ALIGN-IR software by LiCOR biosciences to confirm mutations.
2.10 FREEZER STORAGE OF BACTERIAL STRAINS
For long-term storage of bacterial cultures, stationary phase cells in Medium E 108 with
7% dimethylsulfoxide (DMSO) were dispensed into 2 mL Nalgene cryogenic vials (ThermoFisher 5012-0012) and stored at -80°C. For storage of multiple stocks, 96 well microtiter plates
were used instead of individual vials. Each well of a 96 well microtiter plate (Thermo-Fisher 14230-232) containing 200µL of LB-Amp100 was inoculated with a single bacterial colony. The
plates were incubated with shaking in a HiGro Microplate Cell Incubator (DigiLab) at 37°C
overnight (16hrs). Following incubation, sterile glycerol was added to a final concentration of
10% w/v, the plates were covered with sterile aluminum adhesive and stored at -80°C.
2.11 GREEN FLOURESCENT PROTEIN ASSAY
Bacteria were cultured in a 96 well plate in LB with the appropriate antibiotic overnight
at 37°C in a HiGro Microplate Cell Incubator (DigiLab) and shaken at 500 rpm with positive

41
aeration. When the cultures reached stationary phase, they were diluted in LB-IPTG and the
appropriate antibiotic and incubated for 24 hours at 500 rpm in the HiGro. At the end of the
incubation, the cultures were pelleted in a Sorvall® Legend T centrifuge at 1000 x g for 3
minutes. The supernatant was discarded, the pellets were washed twice in 200µl of HN buffer
(20mM Hepes pH 7.4, 0.85% NaCl) and resuspended in 200 µL of HN buffer and a 150 µL
aliquot was transferred a microtiter plate (Costar clear-bottom assay plate #3631) and the A600
and fluorescence were measured in a SPECTRAMax® 190 absorbance microplate reader and a
SPECTRAmax GeminiTM XPS Fluorescence Microplate Reader (Molecular Devices). The A600
and fluorescence measurements (excitation 395 nM, emission 509 nM) were performed in
triplicate, and the mean fluorescence per A600 was calculated for each of the mutants and
presented as a percentage of the wild-type control cells. Measurements of cells containing the
plasmid pWK122 were used as a blank for all samples. The final GFP activity data are the
average of three analyses conducted from three separate overnight cultures on three separate
days. Standard errors were calculated and presented.
2.12 RIBOSOME PREPARATION
Ribosomes were prepared essentially by the method of Jelenc and edited Spedding.

117; 118

Cells containing pRNA plasmids were grown to A600 = 1.0 and the rrnB operons of the plasmids
were induced with 1 mM IPTG. Induced cultures were incubated at 37 °C to mid log phase (A600
= 0.6-0.8) and immediately cooled on ice. The cells were pelleted in Sorvall tubes using the
SLA 1500 rotor at 4°C, 10min at 5,000 x g and then resuspended in 4 mL Buffer A (50mM TrisHCl, pH 7.6, 10mM MgCl2, 100mM NH4Cl, 500mM EDTA) and lysed in a French Pressure Cell
once at 18000 psi. DNaseI was added to the lysate to a final concentration of 5µg/mL and
incubated on ice for five minutes. The cells were pelleted at 7,000 x g at 4 °C using a Sorval SS-
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34 rotor, for 15 minutes. The supernatant was collected and NH 4Cl was added to a final
concentration of 500 mM. Ribosomes were pelleted by ultracentrifugation at 100,000 x g for
4 hrs at 4° C in a T-1270 rotor (Sorvall). The buffy coat on the surface of the pellet was removed
by gently swirling the pellet twice with 1mL of Buffer B (50 mM Tris-HCl, pH 7.4, 10mM
MgCl2, 100mM NH4Cl). The resulting ribosome pellet was then resuspended in 500 µL Buffer
B by 4 °C incubation overnight and either used immediately or stored at -80° C.
2.13 SUCROSE GRADIENT SEPARATION
Sucrose gradients were prepared (10% and 30% sucrose, 7.5 mM MgCl2, 48 mM Tris pH
7.6, 100mM NH4Cl) and loaded into a 36 mL polyallomer Beckman centrifuge tube (9/16 x 3.5
in). The gradient was created using a Biocomp® Gradient Master™ at angle 76, speed 25 for
2.5 minutes. Each sucrose gradient had 20 A260 units of ribosomes added to it and centrifuged at
21,000 x g for 21 hours at 4° C. 1.0 mL fractions of each gradient were collected and the A 260 of
each fraction was measured and plotted to identify the location of the ribosome peaks in the
gradients.
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PCR Primers
Primer

Sequence (5' to 3')

570N 571N

GTG CCA GCA GCC GCG GTA ATA CGG AGG GTG CAA GCG
TTA ATC GGA ATT ACT GGG CNN AAA GCG CAC GCA GG

16S - H796

CAT CGT TTA CGG CGT GGA CTA CCA GHG TAT CTA ATC
CTG TTT GCT

865N 866N

CCA CCG CTT GTG CGG GCC CCC GTC AAT TCA TTT GAG
TTT TAA CCT TGC GGC CGT ACT CCC CAG GCG GTC GAC
TTA ACG CNN TAGACTC CGG AAG CC

AVR II

ACG TCG CAA GAC CAA AGA GG

Table 2.1: Primers used to create pseudoknot mutations in 16S rRNA
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Specialized PCR Primers
Set

Primer

Sequence (5' to 3')

Set 1

16Set 1A JSL2

5' GCG TCC ACC AGT CCT AGC AAC TCT CAG
ACC AGC TAG GGA T 3'

16Set 1B JSL

5' GCC GTC GCA CTC GTT AGG AAG TCA AAC
TTT TAA ATT GAA GAG 3'

16Set 2A JSL2

5' GCG TCC ACC AGT CCT AGC AAT ACC GCG
GCT GCT GGC ACG G 3'

16Set 2B JSL

5' GCC GTC GCA CTC GTT AGG AAC GCA TAA
CGT CGC AAG ACC AAA G 3'

16Set 3A JSL2

5' GCG TCC ACC AGT CCT AGC AAG GTA TTC
CTC CAG ATC TC 3'

16Set 3B JSL

5' GCC GTC GCA CTC GTT AGG AAG GCC TTC
GGG TTG TAA AGT AC 3'

16Set 4.1A
JSL2

5' GCG TCC ACC AGT CCT AGC AAT TGT GCG
GGC CCC CGT CAA TT 3'

16Set 4B JSL

5' GCC GTC GCA CTC GTT AGG AAA TCC CCG
GGC TCA ACC TTG G 3'

16Set 5A JSL2

5' GCG TCC ACC AGT CCT AGC AAA GTT TAT
CAC TGG CAG TCT C 3'

16Set 5.1B JSL

5' GCC GTC GCA CTC GTT AGG AAT GGA GGT
TGT GCC CTT GAG 3'

16Set 6A JSL2

5' GCG TCC ACC AGT CCT AGC AAT AAT CCC
ATG ATC CAA CCG CAG GTT 3'

16Set 6B JSL

5' GCC GTC GCA CTC GTT AGG AAG CGC AAC
CCT TAT CCT TTG TTG 3'

Set 2

Set 3

Set 4

Set 5

Set 6

Table 2.2: List of specialized PCR primers used for sequencing.
Nucleotides shown in bold are regions that pair with IRD labeled sequencing primers.
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IRD labeled Sequencing Primers

Primer

Sequence

16S seq2
(700)

R

16S seq2
(800)

R

Annealing
Temp

5' IRD700/ CAA AGG ATA AGG GTT GCG GT 3'

65°C

5' IRD800/ GTT ACC CGC AGA AGA AGC AC 3'

65°C

5' IRD700/ GCC GTC GCA CTC GTT AGG AA 3'

68°C

JSL-UniR (800) 5' IRD800/ GCC GTC GCA CTC GTT AGG AA 3'

68°C

JSL2- 800F

68°C

JSL-UniF (700)

5' IRD800/ GCG TCC ACC AGT CCT AGC AA 3'

Table 2.3: List of Infra Red Dye (IRD) sequencing primers.
Nucleotides shown in bold bind to specialized PCR primers in table 2.2.
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Chapter 3
Results
3.1 FUNCTIONAL ANALYSIS OF PSEUDOKNOT MUTATIONS
The pseudoknot in the central domain of the 30S subunit is a convoluted structure
spanning 313 bases, and is characterized by the formation of Watson-Crick base pairing between
G570-C866 and U571-A865 (figure 3.1 and 3.2). A previous study by Vila et al. showed through
mutational analysis that Watson-Crick base pairing at these phylogenetically conserved
nucleotides is critical for ribosome function.73 Using the rRNA plasmid expression vector,
pKK1192U119;

120

, single mutations U571A and A865U of the E. coli 16S rRNA gene that

disrupt Watson-Crick base pairing between these residues were constructed and analyzed.

73

When expressed in vivo, the U571A mutant was lethal and A865U significantly inhibited growth
of the culture. The U571A, A865U double mutant, however, grew normally. Ribosomes with
the single mutations were also less stable than ribosomes from the double mutants as measured
by sucrose gradient profiles of isolated tight couple ribosomes. These data indicate that a
Watson-Crick interaction between nucleotides at positions 571-865 of the 570-571 pseudoknot is
a critical component of ribosome function. However, as this study used only three mutations to
generate these conclusions (U571A, A865U and U571A•A865U), we wondered if there was
more to the observed loss of function besides canonical base pairing. To more thoroughly
examine the structural and functional constraints on the central pseudoknot and its role in
ribosome function we used the high-throughput combinatorial genetic system developed in the
Cunningham Lab39, 110 to construct all possible mutations in the residues hypothesized to form
the pseudoknot and determined their effects on protein synthesis under a variety of in vivo and in
vitro conditions.
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Figure 3.1: Secondary Structure of Nucleotides 570,571 and 865,866
Nucleotides 570, 571 and 865, 866 are shown in E. coli’s 16S secondary structure.

Figure 3.2: Tertiary Structure of Nucleotides 570, 571 and 865, 866
Nucleotides 570, 571, 865, 866 are shown in E.coli’s 16S tertiary structure. Image modified
from PDB 2i2P
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3.2 ANALYSIS OF SINGLE MUTATIONS WITHIN THE PSEUDOKNOT
To begin analyzing the mutant library, we first examined the effects of single mutations
at each of the mutated positions on ribosome function. These data are shown in table 3.1.

Table 3.1: Functional Analysis of Single Mutations.
Red represents the mutated nucleotide. See text for details
570 mutants: In E. coli ribosome crystal structures149, G570 forms a Watson-Crick base
pair with C866, which can be seen in figure 3.3. The transition mutation, G570A (44 ±8%) and
the transversion mutations G570C (44±7%) or G570U (57±10%) each reduce ribosome activity
by approximately 50% in vivo. Mutating G570 to any other nucleotide results in about a 50%
loss of function.
866 mutants: The wild type nucleotide at this position is the pyrimidine cytosine that base
pairs with the guanosine at position 570. This interaction can be seen in figure 3.3. A transition
mutation to uracil leaves the ribosome with 40±3% activity. A transversion mutation to either
adenosine or guanosine results in 59±2% or 53±5% activity respectively. Losing approximately
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50% activity regardless of the nature of the mutation suggests that this position is not largely
influenced by the size of the base.
571 mutants: The wild type nucleotide at this position is the pyrimidine uracil that pairs
with adenosine at position 865 (figure 3.3). Mutating this base to another pyrimidine, cytosine,
the ribosome maintains 61±6% function. However, a transversion mutation to either purine
leaves the ribosome with less than 1% function. These data show that a purine at position 571 is
detrimental to the ribosome.

As purines are larger than pyrimidines, these data show the

damaging steric effect of inserting a large base at 571.
865 mutants: The wild type nucleotide at this position is the purine adenosine and base
pairs with the uracil at position 571. Mutation of this base to a uracil results in 67±3% ribosome
activity. Mutation to a cytosine results in 15±1% activity, and mutation to guanosine results in
21±1% activity.

Figure 3.3: Crystal Structure of Nucleotides 570, 571 and 865,866
Crystal structure modified from PDB 2i2p highlighting the G570-C866, A865-U571 WatsonCrick bond.
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3.3 ANALYSIS OF DOUBLE MUTATIONS WITHIN THE PSEUDOKNOT
By combining the single mutations at positions 570 and 866, we can expand the amount
of information gathered by functional analysis. We can see various canonical and non canonical
base pairs at the same position which will give insight to the types of interactions that are
important for function at this region.
570-866 Double Mutations: Figure 3.4 highlights the interaction between nucleotides 570
and 866. As seen in table 3.2, any combination of mutations will result in loss of 50% ribosome
activity, with the exception of G570U-C866A which is 97±2% active. However, table 3.3 shows
the statistical analysis of canonical double mutant functionality and confirms interactions
between these nucleotides.

We analyze the base interactions by comparing the product of the

single mutants to the observed function of the double mutant that combined the two single
mutations. All three of the other canonical combinations of C-G, U-A and A-U all show a higher

Figure 3.4: Crystal Structure of Nucleotides 570-866 Watson-Crick Bond
Crystal Structure modified from PDB 2i2p highlighting the C866-G570 Watson-Crick bond
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observed function than expected by statistical analysis. While these bases are communicating,
their interactions are not limited to that of traditional Watson-crick base pairing.
571-865 Double Mutations: A close view of nucleotides 571 and 865 within the 571
pseudoknot can be seen in figure 3.5. Table 3.2 shows the functionality of ribosomes with
mutations at both positions 571 and 865. It appears that the interactions between 571 and 865
are more sensitive than at 570 and 866 as many of the double mutants are inactive. The
highlighted boxes show wild type and non-wild type canonical base pairs. These data show that
Watson-crick base pairing is preferred here, with the exception of U571G-A865C having only
10±1% function. However, all mutants containing 571G are dead, which might indicate a steric
problem rather than the inability to form a Watson-crick base pair. Mutants U571C-A865 and
U571-A865U both have high functionality of 61±6% and 67±3%, respectively, but neither form

Figure 3.5: Crystal Structure of Nucleotides 571-865 Watson-Crick Bond.
Crystal Structure of modified from PDB 2i2p highlighting the A865-U571 Watson-Crick bond.
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Watson-crick base pairs. Both of these mutants do, however, maintain a pyrimidine at position
571 and at least one wild type base in the pair. We expected the U571A-A865U mutations to
cause the ribosome to be non-functional based on statistical analysis (Table 3.3) but these
ribosomes maintain 75% function. We see a similar effect with mutations U571C-A865G that
maintain 70% function when we only expected to see about 12% function. These data show that
the bases alone are not responsible for the amount of function these ribosomes maintain.
Statistical analysis of canonical base pairing seen in table 3.3 clearly shows the
interaction between the bases at these positions. We see 75% function in U571A A865U when
the expected function was zero, and observed 70% function for U571C A865G mutations when
only 12% was expected. The only exception is G571-C865, with an expected function of less
than 1% and an observed function of only 10±1%.
3.4 SATURATION MUTAGENESIS OF THE PSEUDOKNOT
PCR saturation mutagenesis98 was used to construct all possible nucleotide combinations
involving 16S rRNA positions 570, 571, 865, and 866 (figure 3.3). The resulting 255 mutants
were then assayed for GFP production in vivo to determine the effect of each set of mutations on
protein synthesis. The resulting mutation database was analyzed to identify key sequence and
structural features of the pseudoknot that are important for ribosome function.
Table 3.4 is a comprehensive table of the ribosomal function of all possible mutations
between nucleotides 570, 571, 865 and 866. This table reveals the clear need for Watson-Crick
base pairing at position 571-865, as without this feature, very few active mutants exist.
Interestingly, regardless of the bases at position 570 or 866, U571-A865 is preferred to U571AA865U and U571C-A865G is preferred to U571G-A865U. Because canonical base-pairs are
isosteric, meaning they occupy the same volume, they should be able to substitute for each
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Table 3.2: Double Mutation Analysis
Highlighed boxes represent canonical base pairs. Red represents mutated bases.

Table 3.3: Double Mutant Statistical Analysis
Nucleotides in bold are wild-type, and those in red are mutant.

Table 3.4: Saturation Mutagenesis Table of Functionality
Letters in bold represent wild type nucleotides.
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other120 (figure 3.6). However, site-directed mutagenesis of 570-866 and 571-865 demonstrates
that the function of different Watson-crick pairs at this position is not equivalent. Consequently,
the individual placement of these particular nucleotides is not arbitrary. Keeping the 570-866
nucleotides constant in a canonical base pair, swapping U571-A865 to U571A-A865U costs the
ribosome a minimum of 21% function and up to 44% of its function. Similar analysis of U571CA865G and U571G-A865C reveals that while 15 of the 16 mutants containing U571C-A865G
are active, only two of the 16 mutants containing U571G-A865C maintain any measurable
function. If this pseudoknot needs to be dynamic for function, then perhaps the simple act of
swapping the orientation of a Watson-Crick bond disrupts a second potential bond somewhere
else in the structure.
A more subtle observation can be seen when looking at the few 570-866 mutations that
maintained measureable function. Even when canonical base pairing is maintained between 570866, most of the mutation combinations proved to be deadly. 570A-866U and 570C-866G

Figure 3.6: Watson Crick Base-Pairs
A) Cytosine-Guanosine; B) Guanosine-Cytosine; C) Uracil-Adenosine; D) Adenosine-Uracil.
Adapted from Leontis et al. 2002. 120
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mutations were only active when combined with a 571-865 Watson-Crick pair. 570G-866C and
570U-866A produced only a handful of functional mutants when combined with noncanonical
571-865 pairs, interestingly most occurred in the presence of U571.
3.5 RIBOSOMAL PROTEIN COMPLEMENTATION
Several ribosomal proteins are near the 571 pseudoknot, namely S5, S8 and S11, as seen
in figure 3.7. Ribosomal protein S5 is within 6Å to the pseudoknot, S8 is within 20Å, and S11 is
within 30Å. To be considered for interaction, a protein should be within 5Å to the nucleotide in
question.121 So while direct interaction of these proteins with the 571 pseudoknot is unlikely,
mutations that disrupt the structure of this region may contribute to loss of rprotein binding. To
determine if mutations in the pseudoknot affect the binding of these proteins, the genes for S8,
S11 and S5 were cloned and co-expressed with representative mutations at each of the sites in
the pseudoknot. Figure 3.8 shows the functional analysis of each of the single pseudoknot
mutations coexpressed with one of the three rproteins. We were looking for a large difference in
the function of the mutant ribosomes that had an empty pKan expression vector (T 1T2) and the
mutant ribosomes that had an abundance of rproteins co-expressed. No complementation was
observed in any of the mutants tested, indicating that loss of function in the mutants is not due to
reduction in binding of ribosomal proteins.
3.6 THERMODYNAMIC INFLUENCE ON THE PSEUDOKNOT
When Vila et al. were investigating the central domain pseudoknot, they attempted to see
a stabilizing effect by monitoring the growth cycle of the three mutants (571A, 865U and 571A865U) at 30°C and 42°C and found that the deleterious growth phenotype was more pronounced
at temperatures lower than 37°C and less pronounced at higher temperatures. 73 Similarly, to
determine the influence of thermodynamics on the activity of the 571 pseudoknot mutants, each
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Figure 3.7: Ribosomal Proteins Near Pseudoknot Nucleotides
Image modified from PDB 2i2p. Ribosomal protein S5 is shown in pink, S8 shown in purple,
S11 shown in orange. See text for full details.
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Figure 3.8: Ribosomal Protein Complementation.
Single mutations in the pseudoknot were co-expressed with ribosomal proteins. T1T2 is the
empty expression vector
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mutant was assayed at 25°C, 30°C, 37°C, and 40°C. Mutants with no measurable protein
synthesis activity at 37°C were unaffected by changes in incubation temperatures, so these data
are not shown.

Mutants with partial activity, however, did vary in function at different

incubation temperatures, in agreement with Vila et al.
We began by analyzing only the single mutants at the four different temperatures, which
can be seen in figure 3.9. These ribosomal mutants were more active at 40°C and were inhibited
by incubation temperatures below 37°C.

We also looked at double mutants at different

temperatures which can be seen in figure 3.10. For a second time, the general trend is a gain of
function at higher temperatures and loss of function at lower temperatures. Interestingly, if the
571-865 pair is U-A (the wild type pair), the function of the ribosome at 25°C is not as
detrimental as it is for the other mutation combinations. Finally, we looked at all the functional
mutants, as seen in figure 3.11 and table 3.5. Again, we see the cold sensitive phenotype and
disproportionate increase in function at higher temperatures.

While base pairing at this

pseudoknot is obviously important to the function of the ribosome, additional factors must also
play a role. These data suggest that the central pseudoknot is dynamic and may facilitate the
switch between two active conformations of rRNA. Mutations in the pseudoknot may therefore
create thermodynamic minima that favor one conformation over the other. Depending on the
role of the conformational switch, the mutations may affect ribosome assembly or one of the
partial reactions during the protein synthesis process itself.
3.7 EFFECTS OF PSEUDOKNOT MUTATIONS ON RIBOSOME STRUCTURE
Mutant ribosomes were prepared under conditions that maintained 70S particles (7.5mM
MgCl2) as to determine if they are capable of assembling into association competent 30S
subunits. Mutations analyzed were selected based on the amount of function they retained and

Figure 3.9: Single Mutation Temperature Analysis
Each single mutation was assayed for function at four different temperatures; 25°C, 30°C, 37°C, and 40°C

Single Mutant Temperature Analysis
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Figure 3.10: Double Mutation Temperature Analysis
Each mutant that maintained Watson-Crick bonds at the pseudoknot was assayed for function at four different temperatures; 25°C,
30°C, 37°C, and 40°C.

Double Mutant Temperature Analysis
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Figure 3.11: Functional Mutant Temperature Analysis
All pseudoknot mutations that displayed measurable function at normal growing temperature (37°C) was assayed for function at
25°C, 30°C, 37°C and 40°C.

Functional Mutant Temperature Analysis
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Functional Mutant Temperature Analysis
570-866
571-865

CU
UA
UA
UA
GC
AU
AC
CG
GC
CG
UG
UA
CC
CG
UA
GC
UA
CG
GG
CG
AU
UA
AU
CG
UU
UA
UU
CG
AG
UA
UC
AU
UA
AU
CG
CG
CU
CG
CG
UA
UC
CG

25°C

30°C 37°C

40°C

0±0

53±2

77±2

84±2

54±8

90±4

97±2

108±5

48±7

53±3

75±6

103±2

27±2

40±2

71±2

83±4

32±6

45±1

70±6

106±9

9±1

44±1

68±4

76±3

31±4

33±1

66±2

77±4

19±3

38±1

64±4

87±8

11±3

25±2

62±4

79±9

13±3

24±1

61±4

63±1

67±6

77±2

60±6

94±1

11±2

24±2

59±4

52±4

46±3

58±2

59±5

82±3

19±1

32±1

59±5

62±5

47±6

56±1

56±5

88±2

13±1

29±1

53±4

70±5

50±5

72±2

53±6

100±6

8±2

23±5

53±2

63±8

15±4

21±1

50±2

50±1

54±6

65±3

50±6

83±15

25±2

50±5

49±6

94±5

570-866
571-865

CA
UA
AA
UA
AG
CG
UG
CG
AU
AU
UA
UU
UA
UC
AC
AU
AU
GC
CG
AU
CC
AU
UA
CU
GC
CU
CA
CG
GA
CG
CG
UU
AA
CG
UA
UG
CA
AU
GG
AU

Table 3.5: Functional Mutant Temperature Analysis
See text for details.

25°C 30°C

37°C

40°C

50±10

55±2

48±3

65±3

32±3

36±1

46±10

64±3

6±1

15±1

46±2

44±3

9±1

22±1

44±3

52±2

3±1

9±2

39±1

43±2

10±1

27±1

36±

61±3

2±0

10±1

35±

34±4

0±0

3±0

30±1

30±3

4±1

13±6

28±1

38±15

26±5

42±2

25±6

63±4

4±2

6±0

24±3

21±1

1±0

6±1

20±2

18±2

2±1

2±0

19±4

12±5

2±1

5±0

18±1

17±2

7±2

10±1

14±2

22±2

2±0

5±0

14±1

12±1

2±1

5±0

14±4

12±1

3±0

6±1

14±2

11±1

1±1

2±0

13±1

10±1

1±0

2±0

13±1

8±1
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compared to wild type ribosome sucrose gradient profiles. Figure 3.12a & b shows the ribosome
profile of selected mutants; Wild Type (100%), G570C-C866U U571-A865 (77±2%), G570CC866G U571C-A865G (53±2%), G570G-C866G U571-A865 (53±5%), G570A-C866U U571AA865U (39±1%), G570U-C865A U571-A865U (36±5%), G570C-C866 U571A-A865U
(24±3%), G570-C866 U571G-A865C (10±1%), G570U-C866U U571G-A865U (2%), G570AC866A U571-A865U (0%).

Figure 3.12a: Ribosome Profile of Select Pseudoknot Mutations
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Figure 3.12b: Ribosome Profile of Select Pseudoknot Mutations
As the observed function decreases, we see a smaller 70S peak compared to the unpaired 50S
and 30S subunits. See text for details.
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The first signs of a decreasing 70S peak and increasing 50S and 30S peaks occur in the
ribosome profile of G570-C866G U571-A865. As the ribosome profiles of other mutants with
less function are analyzed, it is clear that the 70S peaks never quite reaches the OD of the 50S
peaks, though the ratio varies. For example, G570-C866 U571G-A865 (0%) shows a larger 70S
to 50S ratio than G570A-C866U U571A-A865U, which has 39% function. These profiles show
that some mutations inhibit the long-term formation of 70S tight-couples, but it is unclear if the
mutations disrupt association competent 30S subunit.
3.9 MUTANT STRUCTURE-FUNCTION ANALYSIS
Genetic analysis of 571 pseudoknot mutants has revealed a clear relationship between the
ability of the pseudoknot to form Watson-Crick base pairs and function of the ribosome. Data
also suggest the importance of sterics, and therefore the overall structure of the 571 pseudoknot
needs to be analyzed. Due to the difficulty and time requirements of creating crystal structures,
we turned to homology modeling software to evaluate the structure of representative mutations.
Homology models of single mutations at position 571 highlight the importance of sterics
in this structure. When wild-type U571 undergoes a transversion mutation to U571A (seen in
figure 3.13) or U571G (figure 3.14), both the 571 and 865 position become displaced, inhibiting
any kind of potential base pairing between nucleotides 571 and 865, while the 570-866 bond
seems to be unaffected. This is not surprising because functional analysis by GFP production of
these single mutations show these ribosomes are not functional. A transition mutation to U571C
(figure 3.15), however, shows little to no displacement of the nucleotides, which is consistent
with the 60% activity this mutation retains.
We expected to see some distortion of nucleotide positioning in the homology model of
single mutation A865C (figure 3.16) because this transversion mutation reduces the function of
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these ribosomes to only 15±1%. The distorted Watson-Crick interaction between U571 and
A865C seen here is consistent with the loss of function that we observe with most 571-865
mutations. It is worth noting that the distortion is not as prevalent as those observed with position
571 mutations. This suggests that the integrity of the base pairing at the pseudoknot is less
important than the ability to form alternate interactions.
We then compared the proposed structures of two mutants that maintained Watson-Crick
base pairing, but no positions were kept wild-type; G570U-C866A, U571G-A865C (64±4%)
seen in figure 3.17 and G570A-C866U, U571G-A865C (21±1%) seen in figure 3.18. While
some very mild adjustments appear to be present, the amount of distortion is not consistent with
the loss of function observed.

We would expect to see considerably more nucleotide

displacement in mutant G570A-C866U, U571G-A865C than that seen in mutant G570UC866A, U571G-A865C, but because we do not, we have to consider that there is more to this
pseudoknot in terms of functionality than simple Watson-Crick base pairing.
In mutant U571G-A865C (figure 3.19) we see ribosomes with low activity functioning at
10±1%, yet the proposed structure from homology modeling does not suggest an amount of
nucleotide bond distortion proportionate to the amount of function lost. Both G570-C866 and
U571G-A865C appear to have the capability of forming a normal Watson-Crick bond with
minimal interference. Based on the low function of these ribosomes we would expect to see
large bond distortion if Watson-Crick bonding was the driving force for function. However, as
these mutations at position 571 and 865 do not appear to cause much structural discrepancy from
the original proposed model, these data suggest that there are alternate structural formations
needed for the ribosome to be active.
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As we see in these collective data, preserving a Watson-Crick bond does not necessarily
preserve structure or function of the ribosome. Some mutations caused more bond disruptions
than others, but did not correlate with loss of function. From this observation, the data is
consistent with our hypothesis that an alternate structure formation is necessary to keep the
ribosome active, and to do this, particular bases are needed at either position 571 or 865. Also, if
a mutation at position 570 or 866 disrupts the bond formation at 571 and 865, loss of function is
observed.

Figure 3.13: Homology Model of U571A
This mutation leaves the ribosome with no measureable activity.
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Figure 3.14: Homology Model of U571G
This mutation leaves the ribosome with no measureable activity.

Figure 3.15: Homology Model of U571C
This mutation limits the ribosome to 61±6% functionality.
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Figure 3.16: Homology Model of A865C
This mutation creates ribosomes that are 15±1% active.

Figure 3.17: Homology Model of G570U-C866A, U571G-A865C
These ribosomes are 64±4% active.
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Figure 3.18: Homology Model of G570A-G866U, U571G-A865C
These mutations cause the ribosome to be 21±1% active.

Figure 3.19: Homology Model of U571G-A865C
These mutations cause the ribosome to be 10±1% active.
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Chapter 4
Discussion
4.1 FUNCTIONAL ANALYSIS OF SINGLE MUTATIONS
The results of the functional analysis of single mutations in the central pseudoknot
highlight the importance of these nucleotides’ ability to interact with their pairing nucleotides.
We notice that mutating G570 to any other nucleotide reduces ribosome function by
approximately 50% (table 3.1). Since the wild type is a purine, it seems likely that substituting a
smaller pyrimidine residue would not make a difference with respect to steric hindrance. No
preference for either is seen, suggesting that steric hindrance is not the cause for the loss in
function since both transition and transversion mutations yield roughly the same functionality of
the ribosome. At position 866, ribosomes with transition mutations have lower activity than
transversion mutations. Because the wild type is a pyrimidine, we might expect that adding a
purine would cause steric disruption of the local environment and negatively affect ribosome
function. In fact, ribosomes carrying the two purine substitutions are more activity than the
pyrimidine mutants. In the case of positions 570-866, there does not seem to be any indication
of a requirement for base pairing preferences.

In fact, the pair with the second strongest

predicted hydrogen bonding at neutral pH is G570:C866U, which is the single mutant with the
lowest activity.
When we look at ribosomes with mutations at the base pair U571-A865, however, we see
a more interesting pattern in function. All three mutations of U571A:C:G ribosomes only
maintain a significant amount of function in transition mutations, suggesting the need for a small
nucleotide in that position. U571A and U571G ribosomes had no function when assayed while
U571C maintained more than half of wild type function. The most likely explanation for this

73
decrease in functionality in transversion mutations is the involvement of steric hindrance. The
nucleotide at position 571 could be in an area that is very restricted for space and the substitution
of a larger pyrimidine causes the secondary structure to be distorted, possibly disrupting other
important interactions leading to an inactive ribosome. Ribosomes with a mutation at position
865 lose quite a bit of function with the exception of A865U.

Both A865G and A865C

mutations leave the ribosome with very little activity, representing both a transition and
transversion mutation. The corresponding transversion mutation, A865U however, allows the
ribosome to remain more active (67±3%), with over three times more activity than the guanosine
mutation (21±1%). A865U could be forming a U•U wobble pair with U571 which would
explain the higher activity (63±3%), but would not explain why A865G has so little activity
(21±1%). While there is no clear connection between size of the base and ribosome activity at
this position like there is with its opposite base U571, both guanosine and cytosine are rejected
here, even though G•U pairs can be relatively stable157. Therefore, it cannot be concluded that
specific bases are responsible for the loss or preservation of function.
4.2 FUNCTIONAL ANALYSIS OF DOUBLE MUTATIONS
When we analyze the function of various canonical and noncanonical base pairs at
positions 570-866, we see that any combination of mutants reduces ribosome function by about
50%, with the exception of 570U-866A which maintains 97±2% function (see table 3.2). These
data suggest that Watson-Crick base pairing is neither essential, nor preferred. There were no
combination of mutations at position 570 and/or 866 that rendered the ribosome unable to make
protein or unaffected. Whether the mutation created a strong noncanonical base pair, such as
G•U (40±3%), U•G(68±4%), G•A(59±2%), or A•G(56±5%), or a weak noncanonical base pair
such as C•C (44±7%), A•A(46±10%), A•C(44±8%) or U•C(57±10%), ribosomal function was
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roughly equivalent. However, we do see through statistical analysis presented in table 3.3 that
these bases are interacting, as we do not see covariance between mutations and deleterious
phenotypes. For example, ribosomes with mutation G570C function at 44%, and mutation
C866G functions at 53%. If nucleotides 570 and 866 were not interacting, we would expect the
function of G570C-C866G ribosomes to be 23%, but they are in fact 50% active. There is also
no definite indication of steric interactions between these two nucleotides, as function seems to
remain the same regardless of which base is present at these positions.
Functional analyses of double mutations at base pair 571-865 suggest a relationship
between and the steric interactions of bases to activity of the ribosome. As many of the double
mutants are inactive, we can evaluate the similarities and differences of the active mutants to
determine the important qualities of nucleotides at these positions. Watson-Crick base pairing is
clearly preferred, as all of the mutants who maintain a canonical base pair maintain some
measureable amount of function; most even maintain a high amount of function. However, it
can be seen that a guanosine at position 571 is too detrimental to recover function regardless of
its paring nucleotide, leaving most of these pairs with no function at all; U571G•A866 (0%),
U571G•A866C (10±1%), U571G•A866G (0%), U571G•A866U (0%) (see table 3.2). When
considering U571G-A865C has only 10% function, even though the potential to Watson-Crick
base pair is there, we must consider that perhaps the guanosine is being occupied by some other
interaction or twisted out of the pseudoknot completely, withholding its ability to participate in
another interaction the wild type U571 usually partakes in. Mutants U571C-A865 (61±6%) and
U571-A865U (63±3%) both have high function, but neither form Watson-Crick base pairs. Both
of these mutants do, however, maintain a pyrimidine at position 571 and at least one wild type
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base in the pair. Obviously, base pairing for nucleotides 571-865 is important, but there must be
additional factors besides simple base pairing required for function of the ribosome.
4.3 ANALYSIS OF SATURATION MUTAGENESIS
Functional analyses of ribosomes containing mutations at all four positions clearly
demonstrate that Watson-Crick complementarity between nucleotides at position 571 and 865 is
critically important, but we also see that in addition to canonical base pairing, pyrimidines are
strongly preferred at position 571 and purines are strongly preferred at position 865. We can see
in table 3.4 that all the ribosomes with U571-A865 or U571C-A865G maintained function, most
maintained a relatively high amount of function. Saturation mutagenesis data shows very few
ribosomes with U571A-A865U or U571G-A865C mutations maintained function, even though
they still retained canonical base pairing. This trend can be seen when we compare the function
of mutants in which the Watson-Crick pairs are reversed; when all possible base pairs at
positions 570 and 866 are with U571-A865 are compared to the corresponding mutations at
positions 570 and 866 with mutations U571A-A865U, we see a large drop in function.
Similarly, if we look at all possible pairs of mutations for base pairs 570 and 866 and compare
U571C-A865G to U571G-A865C, most mutants lose all function. These patterns suggest that
steric hindrance is a leading factor at position 571; a purine at this position is too large to fit in
the available pocket. We also observe a small cluster of mutants that maintain a wild type uracil
at position 571that have preserved a small amount of measureable function. We do not see this
phenomenon with A865, indicating that U571 may be involved in some other interaction besides
the canonical pair at 865.
Focusing on the 570-866 nucleotide pairs, we see that most of these ribosomes are
inactive regardless of their ability to Watson-Crick base pair unless they are combined with a
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canonical 571-865 pair. Only twelve of the 60 combinations of Watson-Crick base pairs at 570866 with noncanonical pairs at 571-866 had function of at least 10%. When we compare this to
Watson-Crick base pairs at 571-866 to noncanonical pairs at 570-866, there are 43. When we
compare wild type U571-A865 with non-canonical pairs at 570•866, 100% of these mutants
maintain some measureable function. However, wild type G570-C866 when combined with any
noncanonical 571•866, only five of the twelve combinations maintain function, of which, only
three are above 20%. There does not appear to be any preference for one nucleotide over another
at either position 570 or 865. When there is a purine at position 570 with its pyrimidine
canonical pair at 865, there are eleven active mutants. When there is a pyrimidine at position
570 with its purine canonical pair at 865, there are twelve active mutants. While the G570-C865
pair has been shown to be part of the pseudoknot in crystal structures, it does not seem to be
nearly as important as the U571-A865 pair. This is interesting because of the two bonds found in
the pseudoknot, the guanosine-cytosine bond shared between nucleotides 570-866 are known to
be stronger than uracil-adenosine bonds present in the 571-866 bond.
4.4 RIBOSOMAL PROTEIN COMPLEMENTATION
Because we saw an interesting pattern in function involving the 571-865 pair, we
wondered if the bases could be involved in another interaction, potentially with a ribosomal
protein. We chose three ribosomal proteins that bind in the central domain of 30S subunit; S5,
S8 and S11. We chose tertiary binding protein S5 because of its close proximity (less than 8Å in
crystal structures) 149 to the pseudoknot in the 5' and central domains, with known interactions to
bases relatively close to the nucleotides involved in the pseudoknot; 559-560, 921-922, and 923
(the full list of interacting bases are as follows; 5-9, 15-16, 18-19, 559-560, 921-923, 1069-1070,
1072-1074, 1077-1081, 1192-1194, and 1396- 1398).34 We also used primary binding protein
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S8, though farther away from the pseudoknot (about 20Å in crystal structures), we wondered if
the deleterious phenotype was due to early misfolding. S8 is near the center of the back of the
body in the 30S and interacts with S5, making base specific interactions with nucleotides A573,
G575, G858, A859 and the backbone of nucleotides 860, 861 and 560, all of which are very
close to the central domain pseudoknot. Complete nucleotide interactions are as follows: 564,
573, 575, 583, 586-588, 590-591, 593- 600, 629-633, 640-643, 651-654, 810, 820-828, 858-861,
and 872-879. Finally, we chose tertiary binding protein S11 for this complementation assay,
though very distant from the central domain pseudoknot (about 28Å in crystal structures), it is
the closest of the central domain tertiary binding proteins in the 30S.

S11 interacts with

nucleotides 1235-1236, 1242, 1244, 1267-1269, 1285-1286, 1304-1305, 1324-1329, and 13521353.
By increasing the available amount of ribosomal proteins, we could recover function due
to poor binding near the distorted pseudoknot. We over-expressed each of the ribosomal proteins
along with a single mutation at 570, 571, 865, or 866. Wild type ribosomes were coexpressed
with the respective protein and set to 100% for that data set, and compared to mutant ribosomes
that had the same rprotein over-expressed. We also compared these data to single mutant
ribosomes expressed with an empty ribosomal protein expression vector (pKanT 1T2).

If

complementation was occurring, we would have seen a significant difference between the
mutant+T1T2 activity and mutant+rprotein activity. No such increase in activity was observed,
seen in figure 3.8. Some of the single mutant ribosomes activities did not match what was
previously seen in the functional analysis assays (table 3.4), but this could be because these cells
were treated differently (ampicillin + IPTG + chloramphenicol+ arabinose verses ampicillin +
IPTG) and may have been growing slower due to increased cellular stress. The important
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comparison is between single mutants with and without over-expression of ribosomal proteins,
of which we see no considerable difference. While the results of this experiment were negative,
we still gain some insight about this pseudoknot. The loss in function is not due to a reduction in
binding of ribosomal proteins. This is not particularly surprising because the rproteins tested
were a minimum of 6Å away from the pseudoknot and have not been reported to interact with
the nucleotides involved with the pseudoknot.
4.5 THERMODYNAMIC INFLUENCE ON THE PSEUDOKNOT
Raising and lowering optimal growth temperatures of the mutant ribosomes revealed an
interesting, albeit complex, cold-sensitive phenotype also seen by Vila et al. 73 Double stranded
RNA ‘breathes’ at normal temperatures and as heat increases over a small range of temperatures,
it can denature completely.158; 159; 160;161 Because lower temperatures suppress the separation of
strands, convention would tell us that lowering the growth temperature would help to stabilize
the pseudoknot and recover some function from mutant ribosomes with low activity. However,
when we assayed the central domain pseudoknot mutants at different temperatures (25°C, 30°C,
37°C, 40°C), we saw the opposite effect. Dead mutants did not recover any function (this data is
not included) but mutants with activity at 37°C followed a particular growth trend. We first saw
the common trend in single mutants (figure 3.9), as temperature decreased, percent function also
decreased. We then looked at double mutants (figure 3.10), and saw the same trend with the
interesting exception of if wild type U571-A865 was maintained. In this group of mutants where
wild type U571-A865 still remained in the pseudoknot, roughly the same amount of function was
seen at 40°C as 25°C and cold-sensitivity was less pronounced, though this set of mutants still
gained function at 40°C compared to the wild type at the same temperature. When we compared
all the functional mutants at this temperature gradient (figure 3.11), it is clear these mutants do
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not function well in the cold, as we could describe mutations at lower temperatures ‘extremely
deleterious’.
The ribosome is a finely tuned, dynamic machine; any interaction alteration can set off a
wave of changes affecting the structure of the ribosome, which causes the formation of several
different conformational states during protein synthesis. 162

Because simply stabilizing

interactions with colder temperatures does not help to increase ribosomal function, it seems
possible that this pseudoknot is not formed at all times. Considering the complex structures
surrounding both sides of the pseudoknot, it seems likely that even single mutations could
disrupt numerous tertiary structures. Consider position 865; this nucleotide is part of a small
hairpin loop (tetra-loop) with nucleotides 863-866.36 If one or two of these four bases is mutated,
an alternative conformation might be more favorable than the tetra-loop, which might offer some
needed stability in the central domain. The region containing bases 570-571 is even more
complex; the strand itself kinds several times and forms a helix involving bases C569-G881,
G568-C882, G567-C883, and another helix involving G577-C764, C578-G763, and A579-U762.
A common phenotype associated with changes in regions of RNA that are involved in
dynamic structure formation is cold sensitivity. Thus, mutations that stabilize transient structures
will be unable to undergo a conformational change and this may result in acute loss of function
at low temperatures. To test this hypothesis we examined the activity of the mutants at a variety
of temperatures (see section 3.8), and then analyzed the effects of pseudoknot mutations on the
structure of the ribosome (see section 3.9).
4.6 EFFECTS OF PSEUDOKNOT MUTATIONS ON RIBOSOME STRUCTURE
While low temperatures would tend to stabilize RNA structures, the mutations made to
the pseudoknot were extremely deleterious at lower temperatures. This cold sensitivity suggests
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that the pseudoknot is part of a dynamic structure; the involved bases could be engaging in
alternate interactions during a conformational change when they are not forming the pseudoknot.
Mutations might create folding traps which cause the pseudoknot to become permanently locked
in a low energy intermediate or misfolded structure. While the individual domains can assemble
independently, folding of the ribosome is not a trivial process; to assemble a given domain
within the context of full 16S rRNA, folding follows a hierarchical and ordered pathway. Helix
26 (which includes nucleotides 865 and 866 of the pseudoknot) can only associate with
preformed core RNP complex.164

Association of S15 has been shown to induce a

conformational change in a junction between helices 20, 21 and 22 of the 16S rRNA, which
facilitates binding to the central domain. 165 Helix 3 has also been shown to be involved in a
conformational switch during assembly which is coupled to processing of the pre-rRNA and later
steps of 30S subunit assembly.163 Our 571 pseudoknot is located in the central domain where the
3'domain, central domain and the 5'major domain meet, so there is a possibility that these
interactions are what bring these regions of the 16S rRNA into the same area in the 30S subunit.
We wanted to determine if mutant ribosomes are capable of assembling into associationcompetent 30S subunits, so we prepared ribosomes under conditions that would maintain 70S
particles. The first signs of a decreasing 70S peak and increasing 50S and 30S peaks occur in the
ribosome profile of the mutant C866G, which had a function of 53±5%. Among the other low
function mutants, the 70S peaks never quite reaches the OD of the 50S peaks, though the ratio
varies. For example, U571G, which shows no measurable function, displays a larger 70S to 50S
ratio than G570A-C866U U571A-A865U, which has 39% function. These profiles show that
some mutations inhibit the long-term formation of 70S tight-couples, but it is unclear if the
mutations disrupt association-competent 30S subunits. It is possible that the 571-865 base pair
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needs to be a dynamic interaction that must be able to break and reform, with the 571 base
involved in a second interaction.

This hypothesis would explain why the U571A-A865U

mutation is more active than the U571G-A865C and U571C-A865G mutations because the
guanosine-cytosine pair is too strong. This would also explain why preserving the wild-type
uracil at position 571 allows the ribosome to maintain some function regardless of its pairing
nucleotide at position 865. It seems that this nucleotide pair plays a key role in ribosome
function.
4.7 MUTANT STRUCTURE-FUNCTION ANALYSIS
Genetic analysis of 571 pseudoknot mutants has revealed a clear relationship between the
ability of the pseudoknot to form Watson-Crick base pairs and the function of the ribosome.
Data also suggest the importance of sterics, and therefore we wanted to analyze the overall
structure of the 571 pseudoknot. In addition, based on the crystal structure of the 30S published
by Ramakrishnan in 2002 (figure 1.10) and secondary structure pictures (figure 1.9), it appears
that if this pseudoknot is dynamic, alternate base pairing could be possible with adjacent
nucleotides 572 or 864. We turned to homology modeling software to help us analyze the
structure of representative mutations.
Homology models of single mutations at position 571 highlight the importance of sterics
in this structure. When the wild-type nucleotide undergoes a transversion mutation to U571A
(seen in figure 3.13) or U571G (figure 3.14), both the 571 and 865 position are displaced,
inhibiting their ability to base pair. This is confirmed by the lack of function of these mutants in
genetic assays.

Transition mutation U571C (figure 3.15), however, shows little to no

displacement of the nucleotides, which is consistent with the 60% activity this mutation retains.
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We expected to see some distortion of nucleotide positioning in the homology model of
single mutation A865C because these ribosomes are only 15±1% active. However, while the
mutated base does appear to be tilted, the alteration is not as dramatic as the structures seen in
ribosomes with mutations at position 571.

This is consistent with our hypothesis that the

individual base pairs of the pseudoknot are less important than the ability of these nucleotides to
form alternate interactions. Compensatory mutation U571G-A865C (figure 3.19) shows little to
no displacement and yet these ribosomes retain little function (10±1%). This suggests that loss
of activity due to mutations at these positions is not related to defects in ribosome assembly.
Double compensatory mutants G570U-C866A U571G-A865C (64±4%) (figure 3.17) and
G570A-C865U U571G-A865C (21±1%) (figure 3.18) show little difference in the amount of
nucleotide displacement, yet there is a noteworthy difference in their percent activity.
The first criterion that must be met for active mutants is that they be able to form
Watson-Crick base pairs at the pseudoknot.

However, as we see in these collective data,

preserving a Watson-Crick bond does not necessarily preserve structure or function of the
ribosome. Some mutations caused more bond disruptions than others, but did not correlate with
loss of function. From this observation, the data is consistent with our hypothesis that an
alternate structure formation is necessary to keep the ribosome active, and to do this, particular
bases are needed at either position 571 or 865. Also, if a mutation at position 570 or 866 disrupts
the bond formation at 571 and 865, loss of function is observed. Low functioning or dead
mutants may be due to a defect in association because although there appears to be minimal
distortions in the homology models, sucrose gradients show a decrease in complete 70S subunit
formation. Thus, minor changes in structure surrounding the pseudoknot may disrupt critical
intersubunit bridges.
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4.8 PSEUDOKNOT BASE CONSERVATION
The strong correlation between the bases at positions 571 and 865 and the function of
their ribosomes prompted our investigation of the pseudoknot’s base conservation. The Gutell
lab has compiled information about RNA structure and evolution that has been determined using
comparative sequence analysis.

128

Among the data they have compiled were nucleotide

frequencies of the four bases involved in the 571 pseudoknot. A modified version of the
conservation data can be seen in table 4.1. The base pair frequencies at position 570-866 are
highly conserved among individual phylogenetic domains, but overall, all possible Watson-Crick
base pairs are equally represented with the exception of the A570-U866 base pair. This is not
surprising because many non-wild-type base pair combinations that yield active ribosomes were
observed as long as a Watson-Crick pair was conserved between positions 571-865.
Dissimilarly, U571-A865 is universally conserved throughout all life. In this case, it is curious
that we saw functional ribosomes with any pair other than U571-A865. We found other
canonical base pairs at this position that gave us functional ribosomes which disagrees with the
base conservation data. The importance of this pair merits future research.
4.9 FUTURE DIRECTIONS
It has long been known that protein synthesis is an inherently dynamic process. Though
we cannot see all of the nucleotide interactions in the crystal structures of static ribosomes, we
know other conformations, and therefore bonds, must exist. Our data suggest this pseudoknot is
dynamic and forms alternate interactions during translation. The tertiary structure of the
pseudoknot seen in figure 4.1 shows nucleotides 572 and 864 are in close enough proximity to be
potential alternate binding partners. Our preliminary data does not suggest that U572 interacts in
a theoretical alternate conformation with A865. However, if A864 and U571 mutants are
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complimentary when mutated and they recover some function to the ribosome, this would
suggest that U571 moves between paring with A865 and A864 during wild-type conformational
changes essential for ribosome function.
Analysis of the crystal structure of this region suggests that the unpaired bases 864 and
572 are close enough to the pseudoknot that they might be interacting with a dynamic bond. To
test this, we have begun to create point mutations at these two residues and combined them with
select single mutations at 571 or 865 to be assayed for function. Our preliminary data indicate
that specific interactions between 572 and 865 are not required for protein synthesis, but that
canonical pairing between 571 and 864 is important for ribosome function.

Table 4.1: 16S rRNA Base Pair Frequencies for Helical Element 570
Data taken from Gutell lab,128 see text for details.
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Figure 4.1: Potential Alternate Binding Partners
We begin to theorize potential alternate binding partners for the dynamic pseudoknot. We
imagine bases A864 or A872 may be involved in the conformational switch. Image modified
from PDB 2i2p.
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ABSTRACT
INVESTIGATION OF A 16S RNA CENTRAL DOMAIN PSEUDOKNOT
by
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Degree: Master of Science
X-ray crystallography of the prokaryotic 30S ribosomal subunit revealed a myriad of
complex RNA-RNA, RNA-protein, and protein-protein interactions. Among these are several
phylogenetically conserved RNA pseudoknots. Pseudoknots are structurally and functionally
diverse RNA secondary structures. They are generally formed by two short complimentary
sequences separated by many bases of single stranded regions or loops. These relatively simple
folds are often yield complex structures that are key components of functionally important
conformational changes in RNA structure. One such pseudoknot is located in the central domain
of the 16S rRNA.
The central domain pseudoknot is formed by Watson-Crick base pairing between G570C866 and U571-A865. Previous studies by other groups show that formation of this pseudoknot
is critical for ribosome function. To examine the role this pseudoknot in ribosome function, we
constructed and assayed all 255 possible mutations at these four residues. Our data show that
disruption of base pairing between positions 570-866 reduces ribosome function by
approximately 50% and that mutations that disrupt pairing between 571-865 completely block
protein synthesis.
Ribosomal proteins S8, S11 and S5 have binding sites near the central pseudoknot. To
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determine if mutations in the pseudoknot affect the binding of these proteins, the genes for S8,
S11 and S5 were cloned and coexpressed with representative mutations at each of the sites in the
pseudoknot. No complementation was observed in any of the mutants tested, indicating that loss
of function in the mutants is not due to reduction in binding of ribosomal proteins.
To determine the influence of thermodynamics on the activity of the mutants, each
mutant was assayed at 25°C, 30°C, 37°C, and 40°C. Mutants with no measurable protein
synthesis activity at 37° were unaffected by changes in incubation temperatures. Mutants with
partial activity, however, were slightly more active at 40°C but were strongly inhibited by
incubation temperatures below 37°C. These data suggest that the central pseudoknot is dynamic
and may facilitate the switch between two active conformations of rRNA. Mutations in the
pseudoknot may therefore create thermodynamic minima that favor one conformation over the
other.

Homology modeling and ribosome profiles suggest that the mutations may affect

ribosome association or one of the partial reactions during the protein synthesis process itself.
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